Healthcare Connection – Oct. 20, 2015
HRSA Releases Proposed 340B Mega-Guidance
Health Resources and Services Administration has released its long-awaited proposed 340B Drug Pricing Program Omnibus Guidance. Healthcare organizations subject to the guidance should begin to evaluate the proposed changes and discover the potential financial and operational effects of compliance.
Healthcare M&A: Critical Issues in Today’s Fast-Paced Market
What’s driving the robust merger and acquisition (M&A) activity in the healthcare industry? What does it mean for financial executives? Here are some factors to consider.